PhysioSonics, Inc., a Seattel, WA-based provider of noninvasive neurologic monitor solutions, closed its Series B financing.
The round, whose amount reamined undisclosed, was co-led by Kirby Cramer, former Chairman of SonoSite (NASDAQ: SONO), and a strategic investor from the Series A funding.
Mr. Cramer was named Chairman replacing founder Robert Frederickson Ph.D., who will continue to sit on the Board.
PhysioSonics intends to use the proceeds from the financing to commercialize its noninvasive neurology/cardiology monitor through the FDA approval process.
Led by Brad Harlow, President& CEO, the company has developed a non-invasive system for neuro-monitoring with proprietary technology and IP. Its product line provides improved management for traumatic brain injury, brain hemorrhage and interoperative monitoring in both cardiology and neurology.
Founders include Robert Frederickson Ph.D., Michel Kliot M.D., Pierre Mourad, Ph.D., and Jeffrey Jarvik, M.D., MPH who developed the technology at the University of Washington.